Vysioneer

📍 Cambridge, United States🗓 Founded 2019👥 9 employees💰 Last funded Jul 2023
Software Development🌐 vysioneer.com
Website LinkedIn
Vysioneer is an oncology AI company. We aim to improve the clarity about tumor heterogeneity in cancer treatment with lesion-level data. Leveraging our FDA-cleared AI platform, we help pharma companies unlock lesion-level tumor characteristics to de-risk and accelerate clinical trials. Vysioneer is using the AI platform to build the world’s largest database of lesion-level drug efficacy.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2019
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Vysioneer?
Vysioneer has 1 investors on record on gritt.io, 1 mid-stage.
When did Vysioneer last raise funding?
The most recent investment in Vysioneer recorded on gritt.io was in July 2023.
When was Vysioneer founded?
Vysioneer was founded in 2019.
What industry is Vysioneer in?
Vysioneer operates in Software Development. Find similar Software Development investors on gritt.io.
Where is Vysioneer based?
Vysioneer is headquartered in Cambridge, United States.